Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism MAP3K20 inhibitors(mitogen-activated protein kinase kinase kinase 20 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | - | 10 May 2024 | |
Cardiovascular Diseases | Discovery | - | 10 May 2024 | |
Immune System Diseases | Discovery | - | 10 May 2024 | |
Immune System Diseases | Discovery | - | 10 May 2024 | |
Other Diseases | Discovery | - | 10 May 2024 | |
Other Diseases | Discovery | - | 10 May 2024 |